Director, Devens Digital Plant and Site BI&T Lead at Bristol-Myers Squibb

Devens, Massachusetts, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, ManufacturingIndustries

Requirements

  • Reporting to the Executive Director, Business Insights and Technology (BI&T)- BioPharma Operating Units
  • Directly accountable to the US Biologics Manufacturing Leader
  • Accountable for Manufacturing Digital Operations and support operations of the Devens site, including Commercial and Clinical biologics drug substance manufacturing, site Product Development, and laboratory operations
  • Member of the Devens Site Leadership team and the BioPharma BI&T Leadership team
  • Deep knowledge of shop floor operations
  • People leadership responsibilities for a team of 40+ IT and automation professionals plus consultants and contractors

Responsibilities

  • Lead a matrixed organization composed of both site direct reports and groups of indirect reports to deliver effective, innovative, and foundational solutions that realize the site’s next generation digital vision of a Smart Factory
  • Lead, mentor, and develop a high-performing information technology team, fostering a culture of innovation, collaboration, and continuous improvement
  • Strong contributor to the Biologics Operations Leadership Team and develops strategic and collaborative partnerships with them; trusted partner and advisor to all stakeholders on site
  • Responsible for the strategic planning and delivery of digital capabilities for Devens Commercial and Clinical Manufacturing, Devens site Product Development (automation), and Laboratory Operations that ensure maximal use of the site manufacturing capacity
  • Provide automation hardware and IT infrastructure support for the Devens Cell Therapy facility
  • Responsible for 24x7 operational support across all capabilities with a primary focus on automation (control systems), information technology, site infrastructure and computer system validation used in manufacturing and laboratories operations
  • Responsible for strategic delivery of digital capabilities required to prosecute the BMS biologics pipeline with agility and urgency
  • Responsible for strategic alignment of site digital QC Lab operations, in partnership with GPS business applications teams, across all commercial sites
  • Oversee the development and management of the IT budget, ensuring alignment with financial goals; negotiate and manage contracts with IT vendors, service providers, and consultants

Skills

Digital Plant Operations
BI&T
Manufacturing Digital Operations
Biologics Manufacturing
Data Science
Artificial Intelligence
Site Operations
Production Optimization

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI